Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov 15;15(22):6748-50.
doi: 10.1158/1078-0432.CCR-09-2305. Epub 2009 Nov 10.

Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy?

Andrea P Myers  1 , Jeffrey A Meyerhardt, Lewis C Cantley
Affiliations

Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy?

Andrea P Myers et al. Clin Cancer Res. .

Abstract

There is high morbidity associated with local recurrence of rectal cancer. However, the adjuvant therapies given to prevent such recurrences also have significant side effects and associated risks. The ability to select patients with the highest risk of recurrence and greatest therapeutic response will improve rectal cancer care.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A schematic of receptor tyrosine kinase (RTK) activation of the PI3K and RAS-ERK pathways. The molecules in red demarcate the targets of drugs in early stage clinical trials. Studies in the preclinical arena suggest that single agent treatment with targeted drugs may be of utility in small genetic subsets. However, because of redundancy, negative feedback loops, and the genetic complexity of most tumors, these drugs may need to be used in combinations for their ultimate clinical success (9).
See this image and copyright information in PMC

References

    1. He Y, Van't Veer LJ, Mikolajewska-Hanclich I, et al. PIK3CA mutations predict local recurrences in rectal cancer patients. Clin Cancer Res. 2009;15:6956–62. - PubMed
    1. NIH consensus conference Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444–50. - PubMed
    1. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46. - PubMed
    1. Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum. 1993;36:564–72. - PubMed
    1. Medical Research Council Rectal Cancer Working Party Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Lancet. 1996;348:1610–4. - PubMed

Substances